| Literature DB >> 33008821 |
Judith Pöppe1, Katrin Bote1, Abhinaya Ramesh1, Jayaseelan Murugaiyan1,2, Benno Kuropka3, Michael Kühl1, Paul Johnston4,5,6, Uwe Roesler1, Olga Makarova7.
Abstract
Evolution of bacterial tolerance to antimicrobials precedes evolution of resistance and may result in cross-tolerance, cross-resistance, or collateral sensitivity to other antibiotics. Transient exposure of gut bacteria to glyphosate, the world's most widely used herbicide, has been linked to the activation of the stress response and changes in susceptibility to antibiotics. In this study, we investigated whether chronic exposure to a glyphosate-based herbicide (GBH) results in resistance, a constitutive activation of the tolerance and stress responses, and cross-tolerance or cross-resistance to antibiotics. Of the 10 farm animal-derived clinical isolates of Salmonella enterica subjected to experimental evolution in increasing concentrations of GBH, three isolates showed stable resistance with mutations associated with the glyphosate target gene aroA and no fitness costs. Global quantitative proteomics analysis demonstrated activation of the cellular tolerance and stress response during the transient exposure to GBH but not constitutively in the resistant mutants. Resistant mutants displayed no cross-resistance or cross-tolerance to antibiotics. These results suggest that while transient exposure to GBH triggers cellular tolerance response in Salmonella enterica, this response does not become genetically fixed after selection for resistance to GBH and does not result in increased cross-tolerance or cross-resistance to clinically important antibiotics under our experimental conditions.IMPORTANCE Glyphosate-based herbicides (GBH) are among the world's most popular, with traces commonly found in food, feed, and the environment. Such high ubiquity means that the herbicide may come into contact with various microorganisms, on which it acts as an antimicrobial, and it may select for resistance and cross-resistance to clinically important antibiotics. It is therefore important to estimate whether the widespread use of pesticides may be an underappreciated source of antibiotic-resistant microorganisms that may compromise efficiency of antibiotic treatments in humans and animals.Entities:
Keywords: Enterobacteriaceaezzm321990; experimental evolution; fitness costs; glyphosate; resistance; tolerance
Mesh:
Substances:
Year: 2020 PMID: 33008821 PMCID: PMC7688225 DOI: 10.1128/AEM.01204-20
Source DB: PubMed Journal: Appl Environ Microbiol ISSN: 0099-2240 Impact factor: 4.792
FIG 1Schematic representation of the evolution experiment. Bacterial cultures were preadapted to the experimental conditions prior to the evolution experiment, where evolving populations were passaged daily 1:100 with the same Roundup LB Plus (RU) concentration and a concentration that was increased by 10 mg/ml, along with the nonselected controls. After the evolution experiments, populations were passaged in the absence of the herbicide and assessed by MIC testing for stability of resistance.
Dynamics of adaptation in the evolution experiment
| Serovar | Isolate no. | MIC before expt (mg/ml) | Highest concn with visible growth (mg/ml) | MIC after expt (mg/ml) | MIC after stability passage (mg/ml) | Day of extinction |
|---|---|---|---|---|---|---|
| 12469 | 40 | 70 | 7 | |||
| 12470 | 40 | 70 | 7 | |||
| 12471 | 40 | 80 | 22 | |||
| 12473 | 40 | 60 | 5 | |||
| 12538 | 80 | 80 | 80 | 80 | 10 | |
| 12541 | 40 | 80 | 13 | |||
| 12543 | 40 | 60 | 5 |
The number of passages equals the number of days of the experiment before extinction. Resistant isolates that were subjected to whole-genome resequencing are in bold.
Overview of the nonsynonymous mutations detected in GBH-resistant mutants
| Isolate | Affected gene | Type and location of mutations in coding and protein sequences | Protein function |
|---|---|---|---|
| SNP in scaffold_16:G41393A upstream of | 3-Phosphoshikimate 1-carboxyvinyltransferase | ||
| Missense variant c.530G>T/651 p.Arg177Leu/216 | Two-component system transcriptional regulator RcsB | ||
| Stop gained c.361G>T/993 p.Glu121*/330 | RNA polymerase sigma factor RpoS | ||
| Missense variant c.289A>G/1284 p.Thr97Ala/427 | 3-Phosphoshikimate 1-carboxyvinyltransferase | ||
| Multiple | 91 missense mutations in prophage genes | Prophage genes | |
| SNP in scaffold_0:G272493A upstream of | 3-Phosphoshikimate 1-carboxyvinyltransferase |
Stable resistant mutants (single colonies after the stability passage) were subjected to whole-genome resequencing and compared to the genomes of the nonevolved controls and ancestors. Mutation locations are indicated as follows: type of mutation, followed by the variant of nucleotide or amino acid present in the ancestor, position (relative to the gene or protein start) at which the substitution occurred, substituted nucleotide or amino acid in the mutant relative to the complete nucleotide coding (c) and translated protein (p) sequences (after the slash). Mutations in the aroA gene encoding the molecular target of glyphosate are shaded in gray. Note that S. Typhimurium 12468 and S. Enteritidis 12539 appear to have the same mutation in the intergenic space upstream of aroA, while S. Typhimurium 12472 has the amino acid substitution in the location previously associated with resistance to glyphosate (47), suggesting a high degree of convergent evolution between these environmental isolates. SNP, single-nucleotide polymorphism.
FIG 2STRING network analysis of the proteome. The combined proteome of four challenged ancestors (A) and that of the three resulting constitutively GBH-resistant mutants (B) are shown, representing proteins involved in the processes known to be affected by glyphosate (production of aromatic amino acids, chelation of iron, and stress response in bacteria) and the 10 most up- and downregulated proteins for each strain. Blue spheres represent downregulated proteins, red spheres represent upregulated proteins, and yellow spheres are proteins which are upregulated in one strain and downregulated in another strain. Proteins highlighted with the same color belong to a functional group.
Susceptibilities to antibiotics in GBH mutants and ancestors
| Agent | Antibiotic class | MIC (mg/liter) and category for | |||||
|---|---|---|---|---|---|---|---|
| Ancestor (40) | Mutant (160) | Ancestor (40) | Mutant (160) | Ancestor (80) | Mutant (160) | ||
| Piperacillin | β-Lactam | ≥128 R | ≥128 R | ≥128 R | ≥128 R | ≤4 S | ≤4 S |
| Piperacillin-tazobactam | β-Lactam–β-lactamase-inhibitor | ≤4 S | ≤4 S | ≤4 S | ≤4 S | ||
| Cefotaxime | 3rd-generation cephalosporin | ≤1 S | ≤1 S | ≤1 S | ≤1 S | ≤1 S | ≤1 S |
| Ceftazidime | 3rd-generation cephalosporin | ≤1 S | ≤1 S | ≤1 S | ≤1 S | ≤1 S | ≤1 S |
| Cefepime | 4th-generation cephalosporin | ≤1 S | ≤1 S | ≤1 S | ≤1 S | ≤1 S | ≤1 S |
| Aztreonam | Monobactam | ≤1 S | ≤1 S | ≤1 S | ≤1 S | ≤1 S | ≤1 S |
| Imipenem | Carbapenem | ≤0.25 S | ≤0.25 S | ≤0.25 S | ≤0.25 S | ≤0.25 S | ≤0.25 S |
| Meropenem | Carbapenem | ≤0.25 S | ≤0.25 S | ≤0.25 S | ≤0.25 S | ≤0.25 S | ≤0.25 S |
| Amikacin | Aminoglycoside | ≤2 R | ≤2 R | ≤2 R | ≤2 R | ≤2 R | ≤2 R |
| Gentamicin | Aminoglycoside | ≤1 R | ≤1 R | ≤1 R | ≤1 R | ≤1 R | ≤1 R |
| Tobramycin | Aminoglycoside | ≤1 R | ≤1 R | ≤1 R | ≤1 R | ≤1 R | ≤1 R |
| Ciprofloxacin | Fluoroquinolone | ≤0.25 R | ≤0.25 R | ≤0.25 R | ≤0.25 R | ≤0.25 R | ≤0.25 R |
| Tigecycline | Glycylcycline | ≤0.5 S | ≤0.5 S | ≤0.5 S | ≤0.5 S | ≤0.5 S | ≤0.5 S |
| Fosfomycin | Epoxide | ≤16 S | ≤16 S | ≤16 S | ≤16 S | ≤16 S | ≤16 S |
| Trimethoprim-sulfamethoxazole | Folate inhibitor-sulfonamide | ≤20 S | ≤20 S | ≤20 S | ≤20 S | ≤20 S | ≤20 S |
MICs were determined using the Vitek2 AST N-248 panel of antibiotics. Changes in MIC between ancestors and mutants are in bold. Numbers in parentheses are concentrations of Roundup LB Plus, in milligrams per milliliter. R, resistant; S, susceptible.
FIG 3Fitness costs. Final biomass (OD600 values at 16 h) was used as a proxy for bacterial fitness in the presence and absence of Roundup LB Plus (RU). M, mutant; A, ancestor. Asterisks indicate statistical significance as determined by the t test (P < 0.05). Note the absence of fitness costs in the absence of RU and the subtle fitness advantage at certain subinhibitory concentrations of RU.